$ALOT
AstroNova, Inc.

2017 Q2 Form 10-Q Financial Statement

#000119312517197235 Filed on June 08, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $24.46M $24.11M
YoY Change 1.44% 8.57%
Cost Of Revenue $15.15M $14.64M
YoY Change 3.52% 11.09%
Gross Profit $9.306M $9.473M
YoY Change -1.76% 4.91%
Gross Profit Margin 38.05% 39.29%
Selling, General & Admin $7.094M $6.482M
YoY Change 9.44% 12.03%
% of Gross Profit 76.23% 68.43%
Research & Development $1.505M $1.444M
YoY Change 4.22% -19.6%
% of Gross Profit 16.17% 15.24%
Depreciation & Amortization $715.0K $625.0K
YoY Change 14.4% 37.36%
% of Gross Profit 7.68% 6.6%
Operating Expenses $8.599M $7.926M
YoY Change 8.49% 4.54%
Operating Profit $707.0K $1.547M
YoY Change -54.3% 6.84%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$48.00K -$52.00K
YoY Change -7.69% -122.22%
Pretax Income $659.0K $1.495M
YoY Change -55.92% -11.12%
Income Tax $147.0K $476.0K
% Of Pretax Income 22.31% 31.84%
Net Earnings $512.0K $1.019M
YoY Change -49.75% -15.85%
Net Earnings / Revenue 2.09% 4.23%
Basic Earnings Per Share $0.07 $0.14
Diluted Earnings Per Share $0.07 $0.14
COMMON SHARES
Basic Shares Outstanding 7.480M shares 7.358M shares
Diluted Shares Outstanding 7.616M shares 7.524M shares

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.80M $23.30M
YoY Change 2.15% -5.67%
Cash & Equivalents $18.64M $14.53M
Short-Term Investments $5.200M $8.800M
Other Short-Term Assets $1.600M $2.600M
YoY Change -38.46% -70.45%
Inventory $20.34M $16.56M
Prepaid Expenses
Receivables $16.05M $15.01M
Other Receivables $0.00 $200.0K
Total Short-Term Assets $61.78M $57.67M
YoY Change 7.12% -7.52%
LONG-TERM ASSETS
Property, Plant & Equipment $9.234M $9.594M
YoY Change -3.75% 10.56%
Goodwill $11.96M $4.521M
YoY Change 164.5% 356.21%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $23.13M $13.47M
YoY Change 71.69% 251.26%
Total Long-Term Assets $32.36M $23.07M
YoY Change 40.31% 84.33%
TOTAL ASSETS
Total Short-Term Assets $61.78M $57.67M
Total Long-Term Assets $32.36M $23.07M
Total Assets $94.14M $80.74M
YoY Change 16.6% 7.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.120M $6.365M
YoY Change -19.56% 56.58%
Accrued Expenses $1.954M $1.917M
YoY Change 1.93% -10.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.104M
YoY Change
Total Short-Term Liabilities $12.34M $11.18M
YoY Change 10.46% 20.95%
LONG-TERM LIABILITIES
Long-Term Debt $7.941M $0.00
YoY Change
Other Long-Term Liabilities $2.438M $900.0K
YoY Change 170.89% -18.18%
Total Long-Term Liabilities $10.38M $900.0K
YoY Change 1053.22% -18.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.34M $11.18M
Total Long-Term Liabilities $10.38M $900.0K
Total Liabilities $23.40M $12.26M
YoY Change 90.82% 17.96%
SHAREHOLDERS EQUITY
Retained Earnings $44.34M $42.71M
YoY Change 3.81% 5.64%
Common Stock $48.70M $46.61M
YoY Change 4.5% 9650.42%
Preferred Stock
YoY Change
Treasury Stock (at cost) $20.99M $20.20M
YoY Change 3.93% 3.09%
Treasury Stock Shares 2.386M shares 2.336M shares
Shareholders Equity $70.74M $68.47M
YoY Change
Total Liabilities & Shareholders Equity $94.14M $80.74M
YoY Change 16.6% 7.83%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $512.0K $1.019M
YoY Change -49.75% -15.85%
Depreciation, Depletion And Amortization $715.0K $625.0K
YoY Change 14.4% 37.36%
Cash From Operating Activities -$770.0K $2.910M
YoY Change -126.46% -2.02%
INVESTING ACTIVITIES
Capital Expenditures $359.0K $195.0K
YoY Change 84.1% -70.18%
Acquisitions $9.007M
YoY Change
Other Investing Activities -$7.440M $1.790M
YoY Change -515.64% -252.99%
Cash From Investing Activities -$7.800M $1.590M
YoY Change -590.57% -187.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.820M -560.0K
YoY Change -1675.0% 51.35%
NET CHANGE
Cash From Operating Activities -770.0K 2.910M
Cash From Investing Activities -7.800M 1.590M
Cash From Financing Activities 8.820M -560.0K
Net Change In Cash 250.0K 3.940M
YoY Change -93.65% 405.13%
FREE CASH FLOW
Cash From Operating Activities -$770.0K $2.910M
Capital Expenditures $359.0K $195.0K
Free Cash Flow -$1.129M $2.715M
YoY Change -141.58% 17.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6729718 shares
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14534000
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2201000
CY2017Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
1611000
CY2017Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
10144000
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31520000
CY2017Q2 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
6796000
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9886003 shares
CY2017Q2 us-gaap Assets
Assets
94140000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
61777000
CY2017Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1322000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
48207000
CY2017Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
5185000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18637000
CY2017Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
2805000
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16053000
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
495000
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5120000
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
370000
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1313000
CY2017Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
677000
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1954000
CY2017Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7941000
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1914000
CY2017Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11184000
CY2017Q2 us-gaap Inventory Gross
InventoryGross
24434000
CY2017Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1104000
CY2017Q2 us-gaap Inventory Net
InventoryNet
20336000
CY2017Q2 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
1715000
CY2017Q2 us-gaap Liabilities
Liabilities
23400000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
94140000
CY2017Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8249000
CY2017Q2 us-gaap Goodwill
Goodwill
11958000
CY2017Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1168000
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2438000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
12344000
CY2017Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
117000
CY2017Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
12082000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23129000
CY2017Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4098000
CY2017Q2 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
393000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9234000
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
40754000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
70740000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.19
CY2017Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
10.89
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
426831 shares
CY2017Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
1595000
CY2017Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
673000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
44341000
CY2017Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
12.19
CY2017Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2385534 shares
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1566000
CY2017Q2 us-gaap Treasury Stock Value
TreasuryStockValue
20990000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
724820 shares
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10043000
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2936000
CY2017Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
2000
CY2017Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6880000
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31098000
CY2017Q1 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
6725000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9834906 shares
CY2017Q1 us-gaap Assets
Assets
83665000
CY2017Q1 us-gaap Assets Current
AssetsCurrent
61423000
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
47524000
CY2017Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
6723000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18098000
CY2017Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
2811000
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15702000
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
492000
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4957000
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
472000
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1056000
CY2017Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
11000
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2171000
CY2017Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1616000
CY2017Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10270000
CY2017Q1 us-gaap Inventory Gross
InventoryGross
23351000
CY2017Q1 us-gaap Inventory Net
InventoryNet
19506000
CY2017Q1 us-gaap Liabilities
Liabilities
13128000
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83665000
CY2017Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5264000
CY2017Q1 us-gaap Goodwill
Goodwill
4521000
CY2017Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
1216000
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1132000
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
11985000
CY2017Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
366000
CY2017Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
11865000
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12962000
CY2017Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3845000
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9280000
CY2017Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
40378000
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
70537000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.96
CY2017Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
1449000
CY2017Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
708000
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
44358000
CY2017Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
2375076 shares
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1394000
CY2017Q1 us-gaap Treasury Stock Value
TreasuryStockValue
20781000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
685456 shares
CY2017Q2 us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
19000
CY2017Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5000
CY2017Q2 dei Entity Registrant Name
EntityRegistrantName
AstroNova, Inc.
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
472214 shares
CY2017Q2 dei Document Type
DocumentType
10-Q
CY2017Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000008146
CY2017Q2 dei Document Period End Date
DocumentPeriodEndDate
2017-04-29
CY2017Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
539000
CY2017Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
288000
CY2017Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2017Q2 dei Amendment Flag
AmendmentFlag
false
CY2017Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2017Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1856000
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2017Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
715000
CY2017Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
255000
CY2017Q2 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
298000
CY2017Q2 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
3000
CY2017Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
7000
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
15152000
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.223 pure
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
24458000
CY2017Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
66000
CY2017Q2 us-gaap Interest Paid
InterestPaid
0
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-48000
CY2017Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1554000
CY2017Q2 us-gaap Gross Profit
GrossProfit
9306000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
8599000
CY2017Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
512000
CY2017Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-211000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
659000
CY2017Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-7802000
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-221000
CY2017Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
155000
CY2017Q2 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
10000
CY2017Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1005000
CY2017Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-259000
CY2017Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9007000
CY2017Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-257000
CY2017Q2 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2017Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
16000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
707000
CY2017Q2 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
0
CY2017Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
527000
CY2017Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
8824000
CY2017Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12000
CY2017Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3179000
CY2017Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
111000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
147000
CY2017Q2 us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> <b>(1) Overview</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad range of specialty printers and data acquisition and analysis systems. Our products are distributed through our own sales force and authorized dealers in the United States. We also sell to customers outside of the United States primarily through our Company offices in Canada, China, Europe, Mexico and Southeast Asia as well as with independent dealers and representatives. AstroNova, Inc. products are employed around the world in a wide range of aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation applications.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The business consists of two segments, Product Identification (previously known as our QuickLabel segment), which includes specialty printing systems sold under the QuickLabel<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">&#xAE;</sup> and TrojanLabel<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">&#x2122;</sup> brand names, and Test&#xA0;&amp; Measurement which includes test and measurement as well as Aerospace systems sold under the AstroNova&#x2122; brand name.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Products sold under the QuickLabel and TrojanLabel brands are used in industrial and commercial product packaging and automatic identification applications to digitally print custom labels and other visual identification marks on demand. Products sold under the AstroNova Test&#xA0;&amp; Measurement brand acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed and analyzed and then stored and presented in various visual output formats. In the aerospace market, the Company has a long history of using its data visualization technologies to provide high-resolution airborne printers and networking systems as well as related hardware and supplies.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Unless otherwise indicated, references to &#x201C;AstroNova,&#x201D; the &#x201C;Company,&#x201D; &#x201C;we,&#x201D; &#x201C;our,&#x201D; and &#x201C;us&#x201D; in this Quarterly Report on Form&#xA0;10-Q refer to AstroNova, Inc. and its consolidated subsidiaries.</p> </div>
CY2017Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-771000
CY2017Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
CY2017Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
359000
CY2017Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
43125 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7615546 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.021 pure
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.31
CY2017Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
135507 shares
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y6M0D
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2017Q2 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.50
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7480039 shares
CY2017Q2 dei Trading Symbol
TradingSymbol
ALOT
CY2017Q2 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
71000
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1505000
CY2017Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
9200000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.366 pure
CY2017Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
94000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
102189 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.11
CY2017Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5238000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017 pure
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
171000
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y6M
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
19700 shares
CY2017Q2 alot Maximum Disposal Restriction As Percentage Of Restricted Stock Units
MaximumDisposalRestrictionAsPercentageOfRestrictedStockUnits
0.50 pure
CY2017Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
74000
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
11.75
CY2017Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y10M25D
CY2017Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
57000
CY2017Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 Segments
CY2017Q2 alot Reservation Of Shares Under Employee Stock Purchase Plan
ReservationOfSharesUnderEmployeeStockPurchasePlan
247500 shares
CY2017Q2 alot Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
2 Equity_Plan
CY2017Q2 alot Proceeds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromPaymentsForIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
306000
CY2017Q2 alot Unrecognized Tax Benefits Increases Resulting From Windfall
UnrecognizedTaxBenefitsIncreasesResultingFromWindfall
14000
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
431133 shares
CY2016Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4491000
CY2016Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
542000
CY2016Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1651000
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2016Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
625000
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1344000
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
179000
CY2016Q2 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
3000
CY2016Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
69000
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
14637000
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.318 pure
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
24110000
CY2016Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
257000
CY2016Q2 us-gaap Interest Paid
InterestPaid
0
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-52000
CY2016Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1598000
CY2016Q2 us-gaap Gross Profit
GrossProfit
9473000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
7926000
CY2016Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
1019000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1495000
CY2016Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1591000
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
327000
CY2016Q2 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
188000
CY2016Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-443000
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
325000
CY2016Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1588000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1547000
CY2016Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
516000
CY2016Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-556000
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000
CY2016Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1647000
CY2016Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
170000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
476000
CY2016Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2914000
CY2016Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
195000
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7524249 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.019 pure
CY2016Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
166661 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7357588 shares
CY2016Q2 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
52000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1444000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.246 pure
CY2016Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
81000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.86
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4831000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.015 pure
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
314000
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2016Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
230000
CY2016Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-128000
CY2016Q2 alot Proceeds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromPaymentsForIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
-40000

Files In Submission

Name View Source Status
0001193125-17-197235-index-headers.html Edgar Link pending
0001193125-17-197235-index.html Edgar Link pending
0001193125-17-197235.txt Edgar Link pending
0001193125-17-197235-xbrl.zip Edgar Link pending
alot-20170429.xml Edgar Link completed
alot-20170429.xsd Edgar Link pending
alot-20170429_cal.xml Edgar Link unprocessable
alot-20170429_def.xml Edgar Link unprocessable
alot-20170429_lab.xml Edgar Link unprocessable
alot-20170429_pre.xml Edgar Link unprocessable
d379017d10q.htm Edgar Link pending
d379017dex105.htm Edgar Link pending
d379017dex311.htm Edgar Link pending
d379017dex312.htm Edgar Link pending
d379017dex321.htm Edgar Link pending
d379017dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending